ORGANIZATION
PhRMA Chair Urges Japan to Rectify PMP Criteria, Narrow Definition of Innovation
Giovanni Caforio, new chair of the Pharmaceutical Research and Manufacturers of America (PhRMA), on October 3 called on Japan to get things right around its recent changes made to the price maintenance premium (PMP) for innovative medicines, accentuating the importance…
To read the full story
Related Article
ORGANIZATION
- PhRMA Slams CEA Expansion, Warns It Undermines Japan Growth Strategy
November 17, 2026
- UCB Japan President Kikuchi to Take Helm of EFPIA Japan
November 13, 2026
- Japan Pharmacy Group Renews Call to Scrap Off-Year Drug Price Revisions
November 13, 2026
- JPMA to Draw Up 2027 Strategic Plan Based on Industry Vision
November 13, 2026
- JMA Renews Backing for Hanako Jimi in 2028 Upper House Race
November 11, 2026
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…





